Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Submitted by
admin
on January 13, 2015 - 4:28pm
Source:
Seeking Alpha
News Tags:
Rexahn
RX-3117
Eli Lilly
Gemzar
solid tumors
Headline:
Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off
Do Not Allow Advertisers to Use My Personal information
